The partnership combines Indoco’s robust portfolio of high-quality, affordable pharmaceutical products with Clarity Pharma’s extensive distribution network and market expertise.

Indoco Remedies Limited, a globally recognized, research-based pharmaceutical company, has announced a strategic distribution partnership with Clarity Pharma, UK. This collaboration aims to launch approximately 20 pharmaceutical products in the UK market over the next 18 months, significantly bolstering Indoco’s footprint in the region.

The partnership combines Indoco’s robust portfolio of high-quality, affordable pharmaceutical products with Clarity Pharma’s extensive distribution network and market expertise. Indoco will continue supplying its existing B2B clients while enhancing its market reach in the UK through Clarity Pharma’s platform.

Commenting on the partnership, Ms. Aditi Panandikar, Managing Director of Indoco Remedies, stated, “This collaboration with Clarity Pharma marks a significant milestone for Indoco. Together, we aim to deliver innovative healthcare solutions to a broader patient base in the UK, further solidifying our position in the global pharmaceutical market.”

Mr. Steve Soper, CEO of Clarity Pharma, remarked, “Today is the start of an exciting journey with Indoco. This partnership will bring an extensive range of high-quality medicines to the UK market, ensuring affordability and better access for patients.”